๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling

โœ Scribed by Sebastian Zimmer; Philip Kahl; Theresa M. Buhl; Susanne Steiner; Eva Wardelmann; Sabine Merkelbach-Bruse; Reinhard Buettner; Lukas C. Heukamp

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
546 KB
Volume
135
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Influence of epidermal growth factor rec
Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer
โœ Makoto Sonobe; Masatsugu Nakagawa; Kazumasa Takenaka; Hiromichi Katakura; Masash ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 117 KB ๐Ÿ‘ 1 views

## Abstract ## Background and Objectives In this paper we examined the influence of epidermal growth factor receptor (EGFR) gene mutations on EGFR expression, downstream mediators, and survival in patients with nonโ€small cell lung cancer (NSCLC). ## Methods We retrospectively analyzed the tumors

Epidermal growth factor ligand/receptor
Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer
โœ Marco Volante; Silvia Saviozzi; Ida Rapa; Paolo Ceppi; Susanna Cappia; Raffaele ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 396 KB

## Abstract ## BACKGROUND. In recent years, molecular insights shed light on the role of the epidermal growth factor receptor (EGFR) in nonsmall cell lung cancer (NSCLC), and new therapeutic agents, such as the EGFR tyrosine kinase inhibitors, were tested successfully, with responsiveness to those

Epidermal growth factor receptor (EGFR)
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressaยฎ, ZD1839) in chemotherapy-resistant non-small cell lung cancer
โœ Sae-Won Han; Pil Gyu Hwang; Doo Hyun Chung; Dong-Wan Kim; Seock-Ah Im; Young Tae ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 351 KB ๐Ÿ‘ 1 views

## Abstract Gefitinib has shown meaningful antitumor activity with tolerable toxicity in chemotherapyโ€refractory NSCLC in previous studies. Moreover, EGFR expression failed to show a correlation with response. In an attempt to identify predictive markers of response, we have investigated the tumora